Abby R Rosenberg1,2,3,4, Karen L Syrjala3,5, Paul J Martin3,5, Mary E Flowers3,5, Paul A Carpenter1,2,3, Rachel B Salit3,5, K Scott Baker1,2,3, Stephanie J Lee3,5. 1. Cancer and Blood Disorders Center, Seattle Children's Hospital, Seattle, Washington. 2. Department of Pediatrics, University of Washington, Seattle, Washington. 3. Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington. 4. Treuman Katz Center for Pediatric Bioethics, Seattle Children's Hospital Research Institute, Seattle, Washington. 5. Department of Medicine, University of Washington, Seattle, Washington.
Abstract
BACKGROUND: Low patient-reported resilience is associated with an ongoing risk of poor health and psychosocial outcomes. Using a large cross-sectional sample of survivors of hematopoietic cell transplantation (HCT), this study explored associations between patient-reported resilience, psychological distress, posttraumatic growth, and health-related quality of life. METHODS: Between July 1, 2013 and June 30, 2014, the annual Fred Hutchinson Cancer Research Center (FHCRC) posttransplant survivorship survey queried patient-reported health and functional status and included instruments assessing psychosocial outcomes: the 10-item Connor-Davidson Resilience Scale, the Posttraumatic Growth Inventory, the Cancer and Treatment Distress measure, and the 12-item Medical Outcomes Study Short Form quality-of-life scale. Multivariate linear and logistic regression models included demographic and health covariates extracted from the FHCRC research database. RESULTS: Among 4643 adult survivors of HCT, 1823 (39%) responded after a single mailing and subsequent reminder letter. The participants' median age was 59 years (interquartile range [IQR], 50-66 years); 52.5% were male, and most were non-Hispanic white. The median time since HCT was 9 years (IQR, 3-18 years). Lower patient-reported resilience was associated with chronic graft-versus-host disease of higher severity, lower performance scores, missing work because of health, and permanent disability (all P < .0001). After adjustments for demographic and health characteristics, patients reporting low resilience scores had higher odds of having psychological distress (odds ratio [OR], 3.0; 95% confidence interval [CI], 2.1-4.3) and being in the lowest quartile for mental health-related quality of life (OR, 5.9; 95% CI, 4.4-8.0). CONCLUSIONS: Patient-reported resilience is independently associated with health and psychosocial outcomes. Future studies must determine whether interventions can bolster resilience and improve survivorship outcomes.
BACKGROUND: Low patient-reported resilience is associated with an ongoing risk of poor health and psychosocial outcomes. Using a large cross-sectional sample of survivors of hematopoietic cell transplantation (HCT), this study explored associations between patient-reported resilience, psychological distress, posttraumatic growth, and health-related quality of life. METHODS: Between July 1, 2013 and June 30, 2014, the annual Fred Hutchinson Cancer Research Center (FHCRC) posttransplant survivorship survey queried patient-reported health and functional status and included instruments assessing psychosocial outcomes: the 10-item Connor-Davidson Resilience Scale, the Posttraumatic Growth Inventory, the Cancer and Treatment Distress measure, and the 12-item Medical Outcomes Study Short Form quality-of-life scale. Multivariate linear and logistic regression models included demographic and health covariates extracted from the FHCRC research database. RESULTS: Among 4643 adult survivors of HCT, 1823 (39%) responded after a single mailing and subsequent reminder letter. The participants' median age was 59 years (interquartile range [IQR], 50-66 years); 52.5% were male, and most were non-Hispanic white. The median time since HCT was 9 years (IQR, 3-18 years). Lower patient-reported resilience was associated with chronic graft-versus-host disease of higher severity, lower performance scores, missing work because of health, and permanent disability (all P < .0001). After adjustments for demographic and health characteristics, patients reporting low resilience scores had higher odds of having psychological distress (odds ratio [OR], 3.0; 95% confidence interval [CI], 2.1-4.3) and being in the lowest quartile for mental health-related quality of life (OR, 5.9; 95% CI, 4.4-8.0). CONCLUSIONS:Patient-reported resilience is independently associated with health and psychosocial outcomes. Future studies must determine whether interventions can bolster resilience and improve survivorship outcomes.
Authors: Eric J Chow; Beth A Mueller; K Scott Baker; Kara L Cushing-Haugen; Mary E D Flowers; Paul J Martin; Debra L Friedman; Stephanie J Lee Journal: Ann Intern Med Date: 2011-07-05 Impact factor: 25.391
Authors: Jonathan Davidson; Dan J Stein; Barbara O Rothbaum; Ron Pedersen; Annette Szumski; David S Baldwin Journal: J Psychopharmacol Date: 2011-09-17 Impact factor: 4.153
Authors: Abby R Rosenberg; Joyce P Yi-Frazier; Claire Wharton; Karen Gordon; Barbara Jones Journal: J Adolesc Young Adult Oncol Date: 2014-12-01 Impact factor: 2.223
Authors: Paul J Martin; George W Counts; Frederick R Appelbaum; Stephanie J Lee; Jean E Sanders; H Joachim Deeg; Mary E D Flowers; Karen L Syrjala; John A Hansen; Rainer F Storb; Barry E Storer Journal: J Clin Oncol Date: 2010-01-11 Impact factor: 44.544
Authors: Jason H Maley; Isabel Brewster; Iris Mayoral; Renata Siruckova; Sarah Adams; Kelley A McGraw; Angela A Piech; Michael Detsky; Mark E Mikkelsen Journal: Ann Am Thorac Soc Date: 2016-08
Authors: Casey A Walsh; Jean C Yi; Abby R Rosenberg; Marie-Laure V Crouch; Wendy M Leisenring; Karen L Syrjala Journal: Psychooncology Date: 2020-08-13 Impact factor: 3.894
Authors: Amy K Keating; Jurgen Langenhorst; John E Wagner; Kristin M Page; Paul Veys; Robert F Wynn; Heather Stefanski; Reem Elfeky; Roger Giller; Richard Mitchell; Filippo Milano; Tracey A O'Brien; Ann Dahlberg; Colleen Delaney; Joanne Kurtzberg; Michael R Verneris; Jaap Jan Boelens Journal: Blood Adv Date: 2019-04-09
Authors: Margaret Bevans; Areej El-Jawahri; D Kathryn Tierney; Lori Wiener; William A Wood; Flora Hoodin; Erin E Kent; Paul B Jacobsen; Stephanie J Lee; Matthew M Hsieh; Ellen M Denzen; Karen L Syrjala Journal: Biol Blood Marrow Transplant Date: 2016-09-19 Impact factor: 5.742
Authors: Yvonne Tran Bui; Matthew A Hathcock; Roberto P Benzo; Marie M Budev; Satish Chandrashekaran; David B Erasmus; Erika D Lease; Deborah J Levine; Karin L Thompson; Bradley K Johnson; Sheila G Jowsey-Gregoire; Cassie C Kennedy Journal: Clin Transplant Date: 2020-09-23 Impact factor: 2.863
Authors: Stephanie J Lee; Brent Logan; Peter Westervelt; Corey Cutler; Ann Woolfrey; Shakila P Khan; Edmund K Waller; Richard T Maziarz; Juan Wu; Bronwen E Shaw; Dennis Confer; Mary M Horowitz; Claudio Anasetti Journal: JAMA Oncol Date: 2016-12-01 Impact factor: 31.777
Authors: Karen L Syrjala; Hélène Schoemans; Jean C Yi; Shelby L Langer; Ahona Mukherjee; Lynn Onstad; Stephanie J Lee Journal: Transplant Cell Ther Date: 2020-09-29